• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Israel·Healthcare·DANE.TA
Share

Danel Stocks

ILA 43270Last Updated 30.10.2026

Issuer Rating

5/7
Performance

Strong

Risk

Moderate

Recommendation

Hold

Market Cap

ILA 8.23M

ILA 43270
Key Takeaways

Risk factor

Poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Operating in Israel, Danel (Adir Yeoshua) Ltd specializes in delivering a comprehensive suite of human resource solutions. The firm's core offerings encompass talent acquisition (recruitment and placement), payroll administration, and project oversight. These services cater to a wide array of sectors, including welfare, education, diverse technological fields (such as high-tech, cleantech, and biotech), finance, insurance, general administration, and senior executive roles. Furthermore, the company provides dedicated nursing services. Beyond its HR portfolio, Danel also manages facilities focused on special education and assisting individuals with learning disabilities. Its extensive client base includes various government ministries, public sector entities, defense-related industries, and numerous private enterprises. Established in 1974, the company maintains its headquarters in Ramat Gan, Israel.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, of fair value on EV/EBITDA

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

02.11.2026 17:42

One of the boldest bets: Marvell will acquire optics developer Lumentum for $115 billion

02.11.2026 17:30

Shares of biotech company Inovio soared 240% following the drug's approval. Is there still upside potential?

02.11.2026 17:08

"Hope for a Breakthrough in the Iran Stalemate": Oil Prices Plunge 4%

02.11.2026 16:18

Morning in New York: The High-Tech Sector Cools Off Ahead of the Election

02.11.2026 16:04

"I know he's an idiot": Ryanair CEO assesses the business benefits of his feud with Musk

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026